In this retrospective cohort study, we found that patients with BOS exhibit both an increase in FANCE expression and decrease in K2C6A expression, suggesting a role for an aberrant repair response, as well as elevated CRP expression, reflecting a low-grade inflammatory response. The gene discussed is FANCE; the disease is Buschke-Ollendorff syndrome.